Skip to main content
NCBI home page
The Texas Heart Institute Journal logoLink to The Texas Heart Institute Journal
. 1991;18(4):250–262.

Current Status of Thrombolytic Therapy in Acute Myocardial Infarction

Bernardo Stein 1,2, Robert Roberts 1,2
PMCID: PMC326349  PMID: 15227407

Full text

PDF
250

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambrose J. A., Alexopoulos D. Thrombolysis in unstable angina: will the beneficial effects of thrombolytic therapy in myocardial infarction apply to patients with unstable angina? J Am Coll Cardiol. 1989 Jun;13(7):1666–1671. doi: 10.1016/0735-1097(89)90362-8. [DOI] [PubMed] [Google Scholar]
  2. Anderson J. L., Rothbard R. L., Hackworthy R. A., Sorensen S. G., Fitzpatrick P. G., Dahl C. F., Hagan A. D., Browne K. F., Symkoviak G. P., Menlove R. L. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase. J Am Coll Cardiol. 1988 Jun;11(6):1153–1163. doi: 10.1016/0735-1097(88)90276-8. [DOI] [PubMed] [Google Scholar]
  3. Bleich S. D., Nichols T. C., Schumacher R. R., Cooke D. H., Tate D. A., Teichman S. L. Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction. Am J Cardiol. 1990 Dec 15;66(20):1412–1417. doi: 10.1016/0002-9149(90)90525-6. [DOI] [PubMed] [Google Scholar]
  4. Brochier M. L., Quilliet L., Kulbertus H., Materne P., Letac B., Cribier A., Monassier J. P., Sacrez A., Favier J. P. Intravenous anisoylated plasminogen streptokinase activator complex versus intravenous streptokinase in evolving myocardial infarction. Preliminary data from a randomised multicentre study. Drugs. 1987;33 (Suppl 3):140–145. doi: 10.2165/00003495-198700333-00023. [DOI] [PubMed] [Google Scholar]
  5. Chesebro J. H., Knatterud G., Roberts R., Borer J., Cohen L. S., Dalen J., Dodge H. T., Francis C. K., Hillis D., Ludbrook P. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation. 1987 Jul;76(1):142–154. doi: 10.1161/01.cir.76.1.142. [DOI] [PubMed] [Google Scholar]
  6. Collen D. Coronary thrombolysis: streptokinase or recombinant tissue-type plasminogen activator? Ann Intern Med. 1990 Apr 1;112(7):529–538. doi: 10.7326/0003-4819-112-7-529. [DOI] [PubMed] [Google Scholar]
  7. Gold H. K., Coller B. S., Yasuda T., Saito T., Fallon J. T., Guerrero J. L., Leinbach R. C., Ziskind A. A., Collen D. Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation. Circulation. 1988 Mar;77(3):670–677. doi: 10.1161/01.cir.77.3.670. [DOI] [PubMed] [Google Scholar]
  8. Golino P., Ashton J. H., McNatt J., Glas-Greenwalt P., Yao S. K., O'Brien R. A., Buja L. M., Willerson J. T. Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosis. Circulation. 1989 Apr;79(4):911–919. doi: 10.1161/01.cir.79.4.911. [DOI] [PubMed] [Google Scholar]
  9. Gore J. M., Sloan M., Price T. R., Randall A. M., Bovill E., Collen D., Forman S., Knatterud G. L., Sopko G., Terrin M. L. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial. Circulation. 1991 Feb;83(2):448–459. doi: 10.1161/01.cir.83.2.448. [DOI] [PubMed] [Google Scholar]
  10. Grines C. L., DeMaria A. N. Optimal utilization of thrombolytic therapy for acute myocardial infarction: concepts and controversies. J Am Coll Cardiol. 1990 Jul;16(1):223–231. doi: 10.1016/0735-1097(90)90482-5. [DOI] [PubMed] [Google Scholar]
  11. Gulba D. C., Barthels M., Westhoff-Bleck M., Jost S., Rafflenbeul W., Daniel W. G., Hecker H., Lichtlen P. R. Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Relevance for the success of therapy. Circulation. 1991 Mar;83(3):937–944. doi: 10.1161/01.cir.83.3.937. [DOI] [PubMed] [Google Scholar]
  12. Gunnar R. M., Passamani E. R., Bourdillon P. D., Pitt B., Dixon D. W., Rapaport E., Fuster V., Reeves T. J., Karp R. B., Russell R. O., Jr Guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to Develop Guidelines for the Early Management of Patients with Acute Myocardial Infarction) J Am Coll Cardiol. 1990 Aug;16(2):249–292. doi: 10.1016/0735-1097(90)90575-a. [DOI] [PubMed] [Google Scholar]
  13. Hanson S. R., Pareti F. I., Ruggeri Z. M., Marzec U. M., Kunicki T. J., Montgomery R. R., Zimmerman T. S., Harker L. A. Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon. J Clin Invest. 1988 Jan;81(1):149–158. doi: 10.1172/JCI113286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Haugeberg G., Bonarjee V., Dickstein K. Fatal intrathoracic haemorrhage after cardiopulmonary resuscitation and treatment with streptokinase and heparin. Br Heart J. 1989 Aug;62(2):157–158. doi: 10.1136/hrt.62.2.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Heras M., Chesebro J. H., Penny W. J., Bailey K. R., Badimon L., Fuster V. Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor. Circulation. 1989 Mar;79(3):657–665. doi: 10.1161/01.cir.79.3.657. [DOI] [PubMed] [Google Scholar]
  16. Hochman J. S., Choo H. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation. 1987 Jan;75(1):299–306. doi: 10.1161/01.cir.75.1.299. [DOI] [PubMed] [Google Scholar]
  17. Hsia J., Hamilton W. P., Kleiman N., Roberts R., Chaitman B. R., Ross A. M. A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators. N Engl J Med. 1990 Nov 22;323(21):1433–1437. doi: 10.1056/NEJM199011223232101. [DOI] [PubMed] [Google Scholar]
  18. Huey B. L., Beller G. A., Kaiser D. L., Gibson R. S. A comprehensive analysis of myocardial infarction due to left circumflex artery occlusion: comparison with infarction due to right coronary artery and left anterior descending artery occlusion. J Am Coll Cardiol. 1988 Nov;12(5):1156–1166. doi: 10.1016/0735-1097(88)92594-6. [DOI] [PubMed] [Google Scholar]
  19. Hull R. D., Raskob G. E., Hirsh J., Jay R. M., Leclerc J. R., Geerts W. H., Rosenbloom D., Sackett D. L., Anderson C., Harrison L. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med. 1986 Oct 30;315(18):1109–1114. doi: 10.1056/NEJM198610303151801. [DOI] [PubMed] [Google Scholar]
  20. Kander N. H., Holland K. J., Pitt B., Topol E. J. A randomized pilot trial of brief versus prolonged heparin after successful reperfusion in acute myocardial infarction. Am J Cardiol. 1990 Jan 15;65(3):139–142. doi: 10.1016/0002-9149(90)90074-b. [DOI] [PubMed] [Google Scholar]
  21. Kase C. S., O'Neal A. M., Fisher M., Girgis G. N., Ordia J. I. Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis. Ann Intern Med. 1990 Jan 1;112(1):17–21. doi: 10.7326/0003-4819-112-1-17. [DOI] [PubMed] [Google Scholar]
  22. Kersschot I. E., Brugada P., Ramentol M., Zehender M., Waldecker B., Stevenson W. G., Geibel A., De Zwaan C., Wellens H. J. Effects of early reperfusion in acute myocardial infarction on arrhythmias induced by programmed stimulation: a prospective, randomized study. J Am Coll Cardiol. 1986 Jun;7(6):1234–1242. doi: 10.1016/s0735-1097(86)80141-3. [DOI] [PubMed] [Google Scholar]
  23. Magnani B. Plasminogen Activator Italian Multicenter Study (PAIMS): comparison of intravenous recombinant single-chain human tissue-type plasminogen activator (rt-PA) with intravenous streptokinase in acute myocardial infarction. J Am Coll Cardiol. 1989 Jan;13(1):19–26. doi: 10.1016/0735-1097(89)90543-3. [DOI] [PubMed] [Google Scholar]
  24. Mauri F., Gasparini M., Barbonaglia L., Santoro E., Grazia Franzosi M., Tognoni G., Rovelli F. Prognostic significance of the extent of myocardial injury in acute myocardial infarction treated by streptokinase (the GISSI trial). Am J Cardiol. 1989 Jun 1;63(18):1291–1295. doi: 10.1016/0002-9149(89)91037-0. [DOI] [PubMed] [Google Scholar]
  25. Muller D. W., Topol E. J. Selection of patients with acute myocardial infarction for thrombolytic therapy. Ann Intern Med. 1990 Dec 15;113(12):949–960. doi: 10.7326/0003-4819-113-12-949. [DOI] [PubMed] [Google Scholar]
  26. Neuhaus K. L., Feuerer W., Jeep-Tebbe S., Niederer W., Vogt A., Tebbe U. Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator. J Am Coll Cardiol. 1989 Nov 15;14(6):1566–1569. doi: 10.1016/0735-1097(89)90399-9. [DOI] [PubMed] [Google Scholar]
  27. O'Connor C. M., Califf R. M., Massey E. W., Mark D. B., Kereiakes D. J., Candela R. J., Abbottsmith C., George B., Stack R. S., Aronson L. Stroke and acute myocardial infarction in the thrombolytic era: clinical correlates and long-term prognosis. J Am Coll Cardiol. 1990 Sep;16(3):533–540. doi: 10.1016/0735-1097(90)90338-p. [DOI] [PubMed] [Google Scholar]
  28. Puleo P. R., Guadagno P. A., Roberts R., Scheel M. V., Marian A. J., Churchill D., Perryman M. B. Early diagnosis of acute myocardial infarction based on assay for subforms of creatine kinase-MB. Circulation. 1990 Sep;82(3):759–764. doi: 10.1161/01.cir.82.3.759. [DOI] [PubMed] [Google Scholar]
  29. Puleo P. R., Perryman M. B. Noninvasive detection of reperfusion in acute myocardial infarction based on plasma activity of creatine kinase MB subforms. J Am Coll Cardiol. 1991 Apr;17(5):1047–1052. doi: 10.1016/0735-1097(91)90828-w. [DOI] [PubMed] [Google Scholar]
  30. Sheehan F. H., Braunwald E., Canner P., Dodge H. T., Gore J., Van Natta P., Passamani E. R., Williams D. O., Zaret B. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial. Circulation. 1987 Apr;75(4):817–829. doi: 10.1161/01.cir.75.4.817. [DOI] [PubMed] [Google Scholar]
  31. Tenaglia A. N., Califf R. M., Candela R. J., Kereiakes D. J., Berrios E., Young S. Y., Stack R. S., Topol E. J. Thrombolytic therapy in patients requiring cardiopulmonary resuscitation. Am J Cardiol. 1991 Oct 15;68(10):1015–1019. doi: 10.1016/0002-9149(91)90488-7. [DOI] [PubMed] [Google Scholar]
  32. Thompson P. L., Aylward P. E., Federman J., Giles R. W., Harris P. J., Hodge R. L., Nelson G. I., Thomson A., Tonkin A. M., Walsh W. F. A randomized comparison of intravenous heparin with oral aspirin and dipyridamole 24 hours after recombinant tissue-type plasminogen activator for acute myocardial infarction. National Heart Foundation of Australia Coronary Thrombolysis Group. Circulation. 1991 May;83(5):1534–1542. doi: 10.1161/01.cir.83.5.1534. [DOI] [PubMed] [Google Scholar]
  33. Topol E. J., George B. S., Kereiakes D. J., Stump D. C., Candela R. J., Abbottsmith C. W., Aronson L., Pickel A., Boswick J. M., Lee K. L. A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction. Circulation. 1989 Feb;79(2):281–286. doi: 10.1161/01.cir.79.2.281. [DOI] [PubMed] [Google Scholar]
  34. Verstraete M., Bernard R., Bory M., Brower R. W., Collen D., de Bono D. P., Erbel R., Huhmann W., Lennane R. J., Lubsen J. Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator. Lancet. 1985 Apr 13;1(8433):842–847. doi: 10.1016/s0140-6736(85)92208-1. [DOI] [PubMed] [Google Scholar]
  35. Verstraete M., Miller G. A., Bounameaux H., Charbonnier B., Colle J. P., Lecorf G., Marbet G. A., Mombaerts P., Olsson C. G. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation. 1988 Feb;77(2):353–360. doi: 10.1161/01.cir.77.2.353. [DOI] [PubMed] [Google Scholar]
  36. White H. D., Rivers J. T., Maslowski A. H., Ormiston J. A., Takayama M., Hart H. H., Sharpe D. N., Whitlock R. M., Norris R. M. Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction. N Engl J Med. 1989 Mar 30;320(13):817–821. doi: 10.1056/NEJM198903303201301. [DOI] [PubMed] [Google Scholar]
  37. Wilcox R. G., von der Lippe G., Olsson C. G., Jensen G., Skene A. M., Hampton J. R. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet. 1988 Sep 3;2(8610):525–530. doi: 10.1016/s0140-6736(88)92656-6. [DOI] [PubMed] [Google Scholar]
  38. Yasuda T., Gold H. K., Yaoita H., Leinbach R. C., Guerrero J. L., Jang I. K., Holt R., Fallon J. T., Collen D. Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparation. J Am Coll Cardiol. 1990 Sep;16(3):714–722. doi: 10.1016/0735-1097(90)90364-u. [DOI] [PubMed] [Google Scholar]

Articles from Texas Heart Institute Journal are provided here courtesy of Texas Heart Institute

RESOURCES